title: Regulating new psychoactive drugs: innovation leading to compromise.
authors.affiliation: National Poisons Centre, Department of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, New Zealand leo.schep@otago.ac.nz.
authors.forename: Leo J
authors.initials: LJ
authors.lastname: Schep
authors.affiliation: Emergency Department, Christchurch Hospital and Christchurch School of Medicine, University of Otago, Christchurch, New Zealand.
authors.forename: Paul
authors.initials: P
authors.lastname: Gee
authors.affiliation: Department of Pharmacology and Clinical Pharmacology, University of Auckland, New Zealand.
authors.forename: Malcolm
authors.initials: M
authors.lastname: Tingle
authors.affiliation: Community Alcohol and Drug Services, Waitemata DHB, New Zealand.
authors.forename: Susanna
authors.initials: S
authors.lastname: Galea
authors.affiliation: Social and Community Health and Centre for Addiction Research, University of Auckland, New Zealand.
authors.forename: David
authors.initials: D
authors.lastname: Newcombe
mesh_terms: D032761:Animal Experimentation / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D009520:New Zealand; D011619:Psychotropic Drugs
chemical_list: D011619:Psychotropic Drugs